salicylsalicylic acid has been researched along with Disease Models, Animal in 9 studies
salicylsalicylic acid: structure
salsalate : A dimeric benzoate ester obtained by intermolecular condensation between the carboxy of one molecule of salicylic acid with the phenol group of a second. It is a prodrug for salycylic acid that is used for treatment of rheumatoid arthritis and osteoarthritis and also shows activity against type II diabetes.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The disposition of SS and SA were evaluated simultaneously using a pharmacokinetic model comprising several transit absorption steps and linear and nonlinear dual elimination pathways for SA." | 1.38 | Pharmacokinetics of salsalate and salicylic acid in normal and diabetic rats. ( Almon, RR; Cao, Y; DuBois, DC; Jusko, WJ, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Leonhard, WN | 1 |
| Song, X | 1 |
| Kanhai, AA | 1 |
| Iliuta, IA | 1 |
| Bozovic, A | 1 |
| Steinberg, GR | 1 |
| Peters, DJM | 1 |
| Pei, Y | 1 |
| Li, J | 1 |
| Chen, C | 1 |
| Zhang, W | 1 |
| Bi, J | 1 |
| Yang, G | 1 |
| Li, E | 1 |
| Davidson, EP | 1 |
| Coppey, LJ | 1 |
| Shevalye, H | 1 |
| Obrosov, A | 1 |
| Yorek, MA | 1 |
| Jung, TW | 1 |
| Youn, BS | 1 |
| Choi, HY | 1 |
| Lee, SY | 1 |
| Hong, HC | 1 |
| Yang, SJ | 1 |
| Yoo, HJ | 1 |
| Kim, BH | 1 |
| Baik, SH | 1 |
| Choi, KM | 1 |
| Panza, F | 1 |
| Solfrizzi, V | 1 |
| Seripa, D | 1 |
| Imbimbo, BP | 1 |
| Lozupone, M | 1 |
| Santamato, A | 1 |
| Tortelli, R | 1 |
| Galizia, I | 1 |
| Prete, C | 1 |
| Daniele, A | 1 |
| Pilotto, A | 1 |
| Greco, A | 1 |
| Logroscino, G | 1 |
| Shrestha, S | 1 |
| Bhattarai, BR | 1 |
| Kafle, B | 1 |
| Lee, KH | 1 |
| Cho, H | 1 |
| Cao, Y | 2 |
| Dubois, DC | 2 |
| Sun, H | 1 |
| Almon, RR | 2 |
| Jusko, WJ | 2 |
9 other studies available for salicylsalicylic acid and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Salsalate, but not metformin or canagliflozin, slows kidney cyst growth in an adult-onset mouse model of polycystic kidney disease.
Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Cyclic AMP; | 2019 |
Salsalate reverses metabolic disorders in a mouse model of non-alcoholic fatty liver disease through AMPK activation and caspase-6 activity inhibition.
Topics: Adipogenesis; AMP-Activated Protein Kinases; Animals; Caspase 6; Caspase Inhibitors; Diet, High-Fat; | 2021 |
Effect of Dietary Content of Menhaden Oil with or without Salsalate on Neuropathic Endpoints in High-Fat-Fed/Low-Dose Streptozotocin-Treated Sprague Dawley Rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Diet; Diet, Fat-Rest | 2018 |
Salsalate and adiponectin ameliorate hepatic steatosis by inhibition of the hepatokine fetuin-A.
Topics: Adiponectin; alpha-2-HS-Glycoprotein; AMP-Activated Protein Kinases; Animals; Diet, High-Fat; Diseas | 2013 |
Tau-based therapeutics for Alzheimer's disease: active and passive immunotherapy.
Topics: Acetylation; Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monocl | 2016 |
Derivatives of 1,4-bis(3-hydroxycarbonyl-4-hydroxyl)styrylbenzene as PTP1B inhibitors with hypoglycemic activity.
Topics: Animals; Anti-Obesity Agents; Blood Glucose; Disease Models, Animal; Fasting; Glucose Tolerance Test | 2008 |
Modeling diabetes disease progression and salsalate intervention in Goto-Kakizaki rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Body Weight; Diabetes Mellitus, Typ | 2011 |
Pharmacokinetics of salsalate and salicylic acid in normal and diabetic rats.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Dia | 2012 |